BackAlgorhythm Holdings Overview

Algorhythm Holdings Total Liabilities

Track Algorhythm Holdings's total liabilities ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$15.29M
114.71% YoYΔ $8.17M vs prior year quarter

Peer average

Loading

Algorhythm Holdings Total Liabilities History

Loading

Algorhythm Holdings vs. peers: Total Liabilities Comparison

Loading

Algorhythm Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Algorhythm Holdings (RIME) FAQ

The latest total liabilities for RIME is $15M as of March 2026. That compares with $7.1M in the prior-year period — up 114.7% year over year. Investors often review this figure alongside Algorhythm Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, RIME's total liabilities moved from $7.1M to $15M — a 114.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Algorhythm Holdings's operating scale or balance-sheet position.

A total liabilities figure of $15M for RIME is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RIME's total liabilities ($15M), review year-over-year change from $7.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Algorhythm Holdings's total liabilities against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.